Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDK9 anticorps (N-Term)

CDK9 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN926890
  • Antigène Voir toutes CDK9 Anticorps
    CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
    Épitope
    • 21
    • 15
    • 10
    • 10
    • 7
    • 5
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reactivité
    • 93
    • 46
    • 20
    • 6
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 90
    • 3
    • 2
    Lapin
    Clonalité
    • 82
    • 13
    Polyclonal
    Conjugué
    • 42
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp CDK9 est non-conjugé
    Application
    • 77
    • 33
    • 26
    • 26
    • 15
    • 12
    • 12
    • 10
    • 9
    • 8
    • 5
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Purification
    Purified
    Immunogène
    CDK9 antibody was raised in rabbit using the N terminal of CDK9 as the immunogen
    Top Product
    Discover our top product CDK9 Anticorps primaire
  • Indications d'application
    WB: 0.2-1 µg/mL
    Optimal conditions should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    Lot specific
    Buffer
    Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
  • Antigène
    CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
    Autre désignation
    CDK9 (CDK9 Produits)
    Synonymes
    anticorps C-2k, anticorps CDC2L4, anticorps CTK1, anticorps PITALRE, anticorps TAK, anticorps wu:fb22e09, anticorps wu:fc06c02, anticorps c-2k, anticorps cdc2l4, anticorps cdk9, anticorps ctk1, anticorps pitalre, anticorps tak, anticorps CDK9, anticorps CG5179, anticorps Dmel\\CG5179, anticorps P-TEF, anticorps P-TEFb, anticorps PTefb, anticorps cyclin dependent kinase 9, anticorps cyclin-dependent kinase 9 (CDC2-related kinase), anticorps cyclin-dependent kinase 9 L homeolog, anticorps cyclin-dependent kinase 9, anticorps Cyclin-dependent kinase 9, anticorps cyclin-dependent kinase 9 S homeolog, anticorps CDK9, anticorps cdk9, anticorps cdk9.L, anticorps Cdk9, anticorps cdk9.S
    Sujet
    CDK9 is the member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to production elongation by phosphorylating the CTD of the large subunit of RNA polymerase II (RNAP II), SUPT5H and RDBP. The CDK9/cyclin-K complex has also a kinase activity toward CTD of RNAP II and can substitute for P-TEFb in vitro. Synonyms: Polyclonal CDK9 antibody, Anti-CDK9 antibody, cyclin-dependent kinase 9 antibody, C-2k antibody, CDC2L4 antibody, PITALRE antibody, TAK antibody.
    Pathways
    Cycle Cellulaire
Vous êtes ici:
Support technique